Koers Miravant Medical Technologies Inc. Other OTC
Aandelen
MRVT
US6046901079
Biotechnologie & Medisch Onderzoek
Omzet 2003 | - | Omzet 2004 | - | Marktkapitalisatie | 36,86 mln. 33,95 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2003 | -7 mln. -6,45 mln. | Nettowinst (verlies) 2004 | -15 mln. -13,82 mln. | EV/omzet 2003 | - |
Nettoschuld 2003 | 11,89 mln. 10,95 mln. | Nettoschuld 2004 | 4,22 mln. 3,89 mln. | EV/omzet 2004 | - |
K/w-verhouding 2003 |
-4,24
x | K/w-verhouding 2004 |
-2,1
x | Werknemers | - |
Dividendrendement 2003 * |
-
| Dividendrendement 2004 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,63% | 115 mld. | |
+13,17% | 107 mld. | |
-12,76% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-7,19% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+6,67% | 14,26 mld. | |
+33,90% | 12,37 mld. | |
-28,60% | 8,28 mld. |